Director of Regulatory Affairs leading global regulatory strategy for Braveheart Bio’s Phase 3 HCM program. Collaborating with cross - functional teams and ensuring successful regulatory submissions.
BB
Braveheart Bio
Currently Hiring
About the company
Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions.
The company is backed by experienced life science investors including Andreessen Horowitz (a16z Bio + Health), Forbion, OrbiMed, Enavate Sciences (a platform of Patient Square Capital), and Frazier Life Sciences.
Braveheart is advancing BHB-1893 through late-stage clinical development with the goal of establishing a new standard of care.
Open jobs
Browse and apply for open jobs at Braveheart Bio.